Carlyle, Brighton Park invest $200 million in drug development firm Indegene

020421 Carlyle, Brighton Park invest $20

.

Download • 78KB

"Carlyle's commitment to the healthcare sector with their global network and deep pharmaceutical expertise, coupled with Brighton Park's deep experience in the technology sector and nuanced understanding of our space, makes the two ideal partners to support our company's continued growth," said Manish Gupta, Co-Founder and CEO of Indegene..."